ID

28927

Descrizione

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00425919

collegamento

https://clinicaltrials.gov/show/NCT00425919

Keywords

  1. 16/02/18 16/02/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

16 febbraio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus NCT00425919

Eligibility Diabetes Mellitus NCT00425919

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women of non-childbearing potential, 18 to 70 years old
Descrizione

Childbearing Potential Absent | Age

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0001779
subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
Descrizione

Diet therapy | Remedial exercise | Antidiabetic Oral Single

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0203988
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0205171
bmi > 23 and < 43
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
for subjects currently treated with 1 antidiabetic medication: hba1c is greater than or equal to 6.8% and less than or equal to 8.5%.
Descrizione

Antidiabetics Therapeutic procedure | Glucohemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0202054
for subjects not currently treated with antidiabetic medications: hba1c is greater than or equal to 7.2% and less than or equal to 9.0%
Descrizione

Antidiabetics Therapeutic procedure Absent | Glucohemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0332197
UMLS CUI [2]
C0202054
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects requiring insulin therapy
Descrizione

Patient need for Insulin regime

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0557978
subjects currently receiving 2 or more oral antidiabetic medications
Descrizione

Antidiabetics Oral Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
Descrizione

Patient need for CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Procedure discontinued (treatment)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C3653708
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0520253
subjects receiving warfarin
Descrizione

Warfarin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0043031
subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
Descrizione

Thiazolidinediones | Exception Procedure discontinued (treatment)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0520253
significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)
Descrizione

Complications of Diabetes Mellitus | Retinal Diseases | Kidney Diseases | Neuropathy Symptomatic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0342257
UMLS CUI [2]
C0035309
UMLS CUI [3]
C0022658
UMLS CUI [4,1]
C0442874
UMLS CUI [4,2]
C0231220

Similar models

Eligibility Diabetes Mellitus NCT00425919

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Childbearing Potential Absent | Age
Item
men and women of non-childbearing potential, 18 to 70 years old
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Diet therapy | Remedial exercise | Antidiabetic Oral Single
Item
subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
boolean
C0012159 (UMLS CUI [1])
C0203988 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
Body mass index
Item
bmi > 23 and < 43
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Therapeutic procedure | Glucohemoglobin measurement
Item
for subjects currently treated with 1 antidiabetic medication: hba1c is greater than or equal to 6.8% and less than or equal to 8.5%.
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0202054 (UMLS CUI [2])
Antidiabetics Therapeutic procedure Absent | Glucohemoglobin measurement
Item
for subjects not currently treated with antidiabetic medications: hba1c is greater than or equal to 7.2% and less than or equal to 9.0%
boolean
C0935929 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0202054 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Patient need for Insulin regime
Item
subjects requiring insulin therapy
boolean
C0686904 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Antidiabetics Oral Quantity
Item
subjects currently receiving 2 or more oral antidiabetic medications
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Patient need for CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Procedure discontinued (treatment)
Item
subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
boolean
C0686904 (UMLS CUI [1,1])
C3653708 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Warfarin
Item
subjects receiving warfarin
boolean
C0043031 (UMLS CUI [1])
Thiazolidinediones | Exception Procedure discontinued (treatment)
Item
subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
boolean
C1257987 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0520253 (UMLS CUI [2,2])
Complications of Diabetes Mellitus | Retinal Diseases | Kidney Diseases | Neuropathy Symptomatic
Item
significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)
boolean
C0342257 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0442874 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial